Jim Simons Genprex, Inc. Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.19 - $0.37 $68,305 - $133,015	359,500 New	359,500 $83,000
Q1 2023 May 12, 2023	SELL	$0.76 - $1.78 $2,730 - $6,395	-3,593 Reduced 6.54%	51,307 $47,000
Q4 2022 Feb 13, 2023	SELL	$1.0 - $58.8 $18,656 - $1.1 Million	-18,656 Reduced 25.36%	54,900 $80,000
Q3 2022 Nov 14, 2022	BUY	$1.32 - $58.0 $97,093 - $4.27 Million	73,556 New	73,556 $104,000
Q1 2022 May 13, 2022	SELL	$1.82 - $3.5 $1.64 Million - $3.16 Million	-903,400 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.21 - $2.7 $348,897 - $778,531	288,345 Added 46.88%	903,400 $1.18 Million
Q3 2021 Nov 12, 2021	SELL	$2.59 - $3.36 $37,453 - $48,588	-14,461 Reduced 2.3%	615,055 $1.65 Million
Q2 2021 Aug 13, 2021	BUY	$3.11 - $4.87 $1.01 Million - $1.58 Million	323,516 Added 105.72%	629,516 $2.11 Million
Q1 2021 May 13, 2021	BUY	$3.66 - $7.67 $1.12 Million - $2.35 Million	306,000 New	306,000 $1.32 Million
Q1 2020 May 14, 2020	SELL	$0.28 - $6.23 $56,198 - $1.25 Million	-200,709 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.24 - $0.75 $31,709 - $99,090	132,121 Added 192.63%	200,709 $64,000
Q3 2019 Nov 13, 2019	BUY	$0.8 - $1.18 $27,920 - $41,182	34,900 Added 103.6%	68,588 $55,000
Q2 2019 Aug 12, 2019	BUY	$1.2 - $1.85 $8,337 - $12,853	6,948 Added 25.98%	33,688 $42,000
Q1 2019 May 14, 2019	BUY	$1.28 - $2.15 $34,227 - $57,491	26,740 New	26,740 $42,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.